• Explore /
  • Poster
  • / A phase I/II dose-escalation study of fractionated and multiple dose 225Ac-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).

A phase I/II dose-escalation study of fractionated and multiple dose 225Ac-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).

Abstract Video & Slides Poster

Authors

null

Michael Sun

Weill Cornell Medicine, New York, NY

Michael Sun , Jones T. Nauseef , Justin M Lebenthal , Muhammad Junaid Niaz , Sharon Singh , Tessa A Chamberlain , Mahelia Bissassar , Amie Patel , Angela Tan , Shankar Vallabhajosula , John Babich , Paul J. Christos , Joseph Osborne , Ana M. Molina , Cora N. Sternberg , David M. Nanus , Neil Harrison Bander , Scott T. Tagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Advanced Prostate Cancer

Track

Prostate Cancer - Advanced

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04506567

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr TPS188)

DOI

10.1200/JCO.2021.39.6_suppl.TPS188

Abstract #

TPS188

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Jones T. Nauseef

First Author: Scott T. Tagawa

First Author: Scott T. Tagawa

First Author: Jones T. Nauseef